A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo
Stanley C. Xie(The University of Melbourne), Leann Tilley(The University of Melbourne), Stephen Brand(Medicines for Malaria Venture), Benigno Crespo, Mufuliat T. Famodimu(Imperial College London), Darren J. Creek(Monash University), Anna Y. Burkhard(Columbia University Irving Medical Center), Kyra A. Schindler(Columbia University Irving Medical Center), Sergio Wittlin(Swiss Tropical and Public Health Institute), Lawrence R. Dick(Millennium Engineering and Integration (United States)), Mina Salimimarand(The University of Melbourne), Craig J. Morton(The University of Melbourne), Dhélio B. Pereira, Tomas Yeo(Columbia University Irving Medical Center), Chia-Wei Tai(The University of Melbourne), Josefine Striepen(Columbia University Irving Medical Center), Alexandra E. Gould(Takeda (United States)), Anna Caroline Campos Aguiar(Universidade Federal de Minas Gerais), Yogesh Khandokar(Australian Nuclear Science and Technology Organisation), Craig A. Hutton(The University of Melbourne), Elisa De La Cruz(Takeda (United States)), David A. Fidock(Columbia University Irving Medical Center), Shih‐Chung Huang(Kaohsiung Armed Forces General Hospital), Michael J. Delves(London School of Hygiene & Tropical Medicine), Steven Langston(Takeda (United States)), Rafael V. C. Guido(Universidade de São Paulo), Michael D. W. Griffin(University of Melbourne), Li‐Ting Ma(Takeda (United States)), Con Dogovski(The University of Melbourne), Dylan B. England(Takeda (United States)), Rianne van der Laak(TropIQ Health Sciences), Yawei Du(The University of Melbourne), Robert Griffin(Takeda (United States)), Ioanna Deni(Columbia University Irving Medical Center), Karin M. J. Koolen(TropIQ Health Sciences), Judith Bolsher(TropIQ Health Sciences), Tayla Rabie(University of Pretoria), Lyn-Marié Birkholtz(University of Pretoria), Yongbo Hu(Takeda (United States)), Francisco‐Javier Gamo
Cited by 5
Related Papers
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
|Nature Communications|2016|350